Holders — by stockHoldings — by fund
Davern Capital Partners, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002003147
$586.5M
disclosed book value
15
positions
12%
largest position share
Positions, as of 2026-06-30
top 15 of 15 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | BNTXBIONTECH SE | 754,550 | $70.2M | 12% |
| 2 | ROIVROIVANT SCIENCES LTD | 1.9M | $68.4M | 11.7% |
| 3 | RPRXROYALTY PHARMA PLC | 1.2M | $64.8M | 11% |
| 4 | IONSIONIS PHARMACEUTICALS INC | 798,709 | $63.3M | 10.8% |
| 5 | INSMINSMED INC | 559,824 | $59.7M | 10.2% |
| 6 | REGNREGENERON PHARMACEUTICALS | 92,640 | $57.8M | 9.8% |
| 7 | LEGNLEGEND BIOTECH CORP | 1.2M | $34.4M | 5.9% |
| 8 | ALNYALNYLAM PHARMACEUTICALS INC | 113,085 | $34.0M | 5.8% |
| 9 | NTRANATERA INC | 118,975 | $32.3M | 5.5% |
| 10 | GPCRSTRUCTURE THERAPEUTICS INC | 446,059 | $23.9M | 4.1% |
| 11 | MLYSMINERALYS THERAPEUTICS INC | 858,753 | $23.2M | 4% |
| 12 | VERAVERA THERAPEUTICS INC | 498,832 | $21.4M | 3.6% |
| 13 | GENBGENERATE BIOMEDICINES INC | 824,679 | $13.9M | 2.4% |
| 14 | PRCTPROCEPT BIOROBOTICS CORP | 464,920 | $10.5M | 1.8% |
| 15 | AVTXAVALO THERAPEUTICS INC | 468,666 | $8.7M | 1.5% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.